Company: ARAI
Filing Date: 2025-03-24
Form Type: S-1/A
Source: 0001641172-25-000350
Chunk: 62

Company: Arrive AI Inc.
Filing Date: 2025-03-24
Form: S-1/A
Chunk 62
---
 in the U.S. or globally; |

| ● | lawsuits                        
 threatened or filed against us; |

| ● | other                                                                                                           
 events or factors, including those resulting from war, incidents of terrorism, or responses to these events and |

| ● | sales                                                                                               
 or expected sales of our common stock by us and our officers, directors and principal stockholders. |

In addition, stock markets have experienced price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. Stock prices of many companies have fluctuated in a manner often unrelated to the operating performance of those companies. These fluctuations may be even more pronounced in the trading market for our common stock shortly following the listing of our common stock on Nasdaq as a result of the supply and demand forces described above. In the past, stockholders have instituted securities class action litigation following periods of market volatility. If we were to become involved in securities litigation, it could subject us to substantial costs, divert resources and the attention of management from our business and harm our business, results of operations and financial condition.

We may not be able to meet each of the quantitative requirements of the Nasdaq Global Market’s Market Value Standard for Direct Listings

We have applied to have our common stock listed on Nasdaq Global Market. We expect that our common stock will be listed on Nasdaq Global Market on or promptly after the date of this prospectus. In order for Nasdaq Global Market to approve our listing application, we will need to meet the quantitative requirements of the Nasdaq Global Market’s Market Value Standard for Direct Listings, as provided in Nasdaq Listing Rules 5405(a) and 5405(b)(3). We expect to meet all those requirements but in the event that we are unable to meet such requirements, we will not be approved to list our common stock on Nasdaq Global Market and our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including:

| ● | a limited availability                                                                                                 
 of market quotations for our securities;                                                                               |
| ● | reduced liquidity for                                                                                                  
 our securities;                                                                                                        |
| ● | a determination that our                                                                                               
 common stock is “penny stock” which will require brokers trading in our common stock to adhere to more stringent rules 
 and possibly result in a reduced level of trading activity in the secondary trading market for our securities;         |
| ● | a limited amount of news                                                                                               
 and analyst coverage; and                                                                                              |
| ●